REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Bacterial and virus strains | ||
Vibrio alginolyticus VIO5, see Table S2 | Okunishi et al.65 | N/A |
Vibrio alginolyticus NMB198, see Table S2 | Yorimitsu et al., 200366 | N/A |
Escherichia coli DH5α, See Table S2 | Grant et al., 199067 | N/A |
Escherichia coli BL21(DE3), See Table S2 | Novagen | Cat#69450-3 |
Escherichia coli S17-1, See Table S2 | Simon et al., 198368 | N/A |
Chemicals, peptides, and recombinant proteins | ||
Deuterium oxide | Wako | Cat#040-18831 |
Ammonium 15N chloride | ISOTEC | Cat#299251-10G |
TALON Metal Affinity Resin | Clontech Laboratories, Inc. | Cat#635501 |
Factor Xa | New England Biolabs | Cat#P8010S |
cOmplete™, EDTA-free Protease Inhibitor Cocktail | Roche Life Science | Cat#11873580001 |
sodium 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) | Cambridge Isotope Laboratories | Cat#DLM-32-1 |
α-ketobutyric acid sodium salt (Methyl-13C; 3,3-2H2) | Cambridge Isotope Laboratories | Cat#CDLM-7318-0.5 |
[δ-13C; α, β, γ12, γ13, γ2, γ2, γ2-2H7; 15N] isoleucine | SAIL Technologies | Cat#I-004 |
[0, α, β, δ1, δ2-13C5; β2, ε1, ε2, ζ-2H4; 15N] phenylalanine | SAIL Technologies | Cat#F-013a |
Critical commercial assays | ||
QuikChange Site-directed Mutagenesis kit | Stratagene | Cat#200516 |
Deposited data | ||
Structure of FliG-FliM from thermotoga maritima | Vartanian et al.62 | PDB: 4FHR |
Cryo-ET volume of Vibrio alginolyticus clockwise locked rotor | Carroll et al.44 | EMDB: EMD-21819 |
Cryo-ET volume of Vibrio alginolyticus counter-clockwise locked rotor | Carroll et al.44 | EMDB: EMD-21837 |
Oligonucleotides | ||
Primer: To generate I140L mutation: CAAGTGGCGAGCTTGATTGTTAACGAACAC |
This study | N/A |
Primer: To generate I140L mutation: GTGTTCGTTAACAATCAAGCTCGCCACTTG |
This study | N/A |
Primer: To generate I141L mutation: CAAGTGGCGAGCATCTTGGTTAACGAACACC |
This study | N/A |
Primer: To generate I141L mutation: GGTGTTCGTTAACCAAGATGCTCGCCACTTG |
This study | N/A |
Primer: To generate I148L mutation: GAACACCCGCAGTTGCAAACCATCGTATTG |
This study | N/A |
Primer: To generate I148L mutation: CAATACGATGGTTTGCAACTGCGGGTGTTC |
This study | N/A |
Primer: To generate I151L mutation: CCGCAGATCCAAACCTTGGTATTGTCTTATTTAG |
This study | N/A |
Primer: To generate I151L mutation: CTAAATAAGACAATACCAAGGTTTGGATCTGCGG |
This study | N/A |
Primer: To generate I164L mutation: CCAATCCGCGGAGTTGTTGTCTCAGTTCC |
This study | N/A |
Primer: To generate I164L mutation: GGAACTGAGACAACAACTCCGCGGATTGG |
This study | N/A |
Primer: To generate I180L mutation: CCTAATGATGCGTTTGGCCAACCTAGAAG |
This study | N/A |
Primer: To generate I180L mutation: CTTCTAGGTTGGCCAAACGCATCATTAGG |
This study | N/A |
Primer: To generate I197L mutation: CAGAGCTGAACGAATTGATGGAGAAACAGTTC |
This study | N/A |
Primer: To generate I197L mutation: GAACTGTTTCTCCATCAATTCGTTCAGCTCTG |
This study | N/A |
Primer: To generate I213L mutation: CAAGCAGCCAAGTTAGGCGGCCTGAAAG |
This study | N/A |
Primer: To generate I213L mutation: CTTTCAGGCCGCCTAACTTGGCTGCTTG |
This study | N/A |
Primer: To generate G214A mutation: CAGCCAAGATTGCGGGCCTGAAAGCGGCA |
This study | N/A |
Primer: To generate G214A mutation: TGCCGCTTTCAGGCCCGCAATCTTGGCTG |
This study | N/A |
Primer: To generate G214S mutation: CAGCCAAGATTAGCGGCCTGAAAGCGG |
This study | N/A |
Primer: To generate G214S mutation: CCGCTTTCAGGCCGCTAATCTTGGCTG |
This study | N/A |
Primer: To generate G214C mutation: CAGCCAAGATTTGTGGCCTGAAAGCGGCA |
This study | N/A |
Primer: To generate G214C mutation: TGCCGCTTTCAGGCCACAAATCTTGGCTG |
This study | N/A |
Primer: To generate G214P mutation: CAGCCAAGATTCCAGGCCTGAAAGCGGCA |
This study | N/A |
Primer: To generate G214P mutation: TGCCGCTTTCAGGCCTGGAATCTTGGCTG |
This study | N/A |
Primer: To generate G215A mutation: CAAGATTGGCGCACTGAAAGCGGCAG |
This study | N/A |
Primer: To generate G215A mutation: CTGCCGCTTTCAGTGCGCCAATCTTG |
This study | N/A |
Primer: To generate G215S mutation: CAGCCAAGATTGGCTCTCTGAAAGCGGCA |
This study | N/A |
Primer: To generate G215S mutation: TGCCGCTTTCAGAGAGCCAATCTTGGCTG |
This study | N/A |
Primer: To generate G215P mutation: CAGCCAAGATTGGCCCACTGAAAGCGGCA |
This study | N/A |
Primer: To generate G215P mutation: TGCCGCTTTCAGTGGGCCAATCTTGGCTG |
This study | N/A |
Primer: To generate G214S/G215A mutation: CAGCCAAGATTAGCGCACTGAAAGCGGCA |
This study | N/A |
Primer: To generate G214S/G215A mutation: TGCCGCTTTCAGTGCGCTAATCTTGGCTG |
This study | N/A |
Primer: To generate I222L mutation: CTGAAAGCGGCAGCGGAGCTGATGA ACTATCTAGACAAC |
This study | N/A |
Primer: To generate I222L mutation: GTTGTCTAGATAGTTCATCAGCTCCG CTGCCGCTTTCAG |
This study | N/A |
Primer: To generate I238L mutation: GGTTTGTTGATGGAGCAGCTGCGC GATCAAGACGAAGAC |
This study | N/A |
Primer: To generate I238L mutation: GTCTTCGTCTTGATCGCGCAGCTG CTCCATCAACAAACC |
This study | N/A |
Primer: To generate I249L mutation: GAAGACATGGCGACGCAACTGCA AGACTTGATGTTTGTC |
This study | N/A |
Primer: To generate I249L mutation: GACAAACATCAAGTCTTGCAGTT GCGTCGCCATGTCTTC |
This study | N/A |
Primer: To generate I267L mutation: GAAGTGGACGATCAAGGTCTGCA GAAATTGCTGCGTGAT |
This study | N/A |
Primer: To generate I267L mutation: ATCACGCAGCAATTTCTGCAGACC TTGATCGTCCACTTC |
This study | N/A |
Primer: To generate I310L mutation: GAGATGATGCGTGATGACCTGGA AGCGATGCCGCCAGTT |
This study | N/A |
Primer: To generate I310L mutation: AACTGGCGGCATCGCTTCCAGGT CATCACGCATCATCTC |
This study | N/A |
Primer: To generate I328L mutation: GAAGCGGCACAGAAAGAACTGC TAGCGATCGCTCGTCGC |
This study | N/A |
Primer: To generate I328L mutation: GCGACGAGCGATCGCTAGCAGT TCTTTCTGTGCCGCTTC |
This study | N/A |
Primer: To generate I331L mutation: CAGAAAGAAATCCTAGCGCTGGC TCGTCGCATGGCCGAT |
This study | N/A |
Primer: To generate I331L mutation: ATCGGCCATGCGACGAGCCAGC GCTAGGATTTCTTTCTG |
This study | N/A |
Primer: To generate F254 mutation: CAAGACTTGATGTACGTCTTCGA AAACTTAG |
This study | N/A |
Primer: To generate F254 mutation: CTAAGTTTTCGAAGACGTACAT CAAGTCTTG |
This study | N/A |
Primer: To generate F256 mutation: GACTTGATGTTTGTCTACGAAAA CTTAGTCGAA |
This study | N/A |
Primer: To generate F256 mutation: TTCGACTAAGTTTTCGTAGACA AACATCAAGTC |
This study | N/A |
Recombinant DNA | ||
pMMB206, see Table S2 | Morales et al., 199169 | N/A |
pNT1, see Table S2 | Takekawa et al.8 | N/A |
pColdI, see Table S2 | Takara | Cat#3361 |
pColdI-FliGMC, see Table S2 | Onoue et al., 201670 | N/A |
Software and algorithms | ||
TopSpin version 3.6.2 | Bruker BioSpin | https://www.bruker.com/service/supportupgrades/software-downloads/nmr.html |
UCSF Chimera X Version 1.5 | UCSF | https://www.cgl.ucsf.edu/chimerax/download.html |
UCSF Chimera, Microsoft Windows 64-bit, Ver 1.16 | UCSF | https://www.cgl.ucsf.edu/chimera/download.html |
GROMACS version 2016.5 | Pronk et al.71 | http://www.gromacs.org |
Pymol, version 2.5.0 | Schrödinger LLC | https://pymol.org/2/ |
MODELLER version 9.6 | Marti-Renom et al. 200072 | https://salilab.org/modeller/ |
NMRFAM-SPARKY | Lee et al.73 | https://nmrfam.wisc.edu/nmrfam-sparky-distribution/ |
Other | ||
Xtreme-60 Syringe pump system | Daedalus Innovations | Cat#Xtreme-60 |
5 mm high pressure zirconia tube | Daedalus Innovations | https://daedalusinnovations.com/high-pressure-nmr/ |
Superdex™ 200 Increase 10/300 GL column | Citiva | Cat#28990944 |